Twist Bioscience Stock Scores Relative Strength Rating Upgrade 2021-05-28T18:15:17-04:00May 28th, 2021| share this article! TwistBioscienceCorp shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 84. Read More share this article! Related Posts Tesla’s AutoPilot Recall Gets New Probe. When to Worry About the Stock., Go to article April 26th, 2024 Buy Enphase Energy Stock, Analyst Says. It’s Only Up From Here., Go to article April 26th, 2024 No Rate Cuts? No Worries. Uncle Sam Has Dough to Disburse., Go to article April 26th, 2024 Berkshire Hathaway’s Real Estate Brokerage Agrees to Pay $250 Million to Settle Commission Lawsuit, Go to article April 26th, 2024
